We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Practical Applications for Quality Improvement in Myelofibrosis Management: A Video Brief on Lessons Learned
Joseph Kim, MD, MPH
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting
Matthew Lunning, DO, FACP
Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ovarian Cancer: PARP Inhibitor-Related Adverse Events and Team-Based Care
Kathleen Moore, MD, MS
Improving Interprofessional Management and Clinical Outcomes with PARP Inhibitors for Advanced Ovarian Cancer: Cytogenetic Testing and PARP Inhibition for Maintenance Treatment
Expert Answers to Common Questions on Response Matters: Transforming the Standard of Care in CML by Mastering Response-Guided Treatment
Michael J. Mauro, MD
Expert Answers to Common Questions for Tailoring ADC Therapies Across the HER2 Spectrum in Metastatic Breast Cancer
Sara M. Tolaney, MD, MPH
Expert Answers to Common Questions for Improving the Road to Remission with CAR T-Cell Therapies in Large B-Cell Lymphoma: Considerations for Community Practice
Caron A. Jacobson, MD
Global Perspectives on PARP inhibitor Combinations in mCRPC Match Play: European vs. US Integration in Practice
Neeraj Agarwal, MD, FASCO
Elena Castro, MD, PhD
Neal Shore, MD, FACS
Axel S. Merseburger, MD
Lowering Burden to Raise Adherence: Optimizing Prophylaxis for Hemophilia A
Guy Young, MD
Incorporating Scientific Advances into Myelofibrosis Treatment Plans
Ruben Mesa, MD, FACP
Taking Command of the Treatment of ESA-Refractory, Transfusion-dependent LR-MDS
Paul P. Doghramji, MD, FAAFP
Rami Komrokji, MD
Allan Platt, PA-C, MMSc
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education